DebioPharm to conduct Phase III trial of Pfizer's melanoma drug

01/8/2010 | CNNMoney

Pfizer tapped DebioPharm Group to conduct a late-stage trial of tremelimumab in patients with unresectable, Stage IV melanoma. Pfizer, which abandoned its own Phase III trial after advice from an independent board, will still be responsible for global marketing of the drug.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT